BioNeutra Global BGACF Stock
BioNeutra Global Price Chart
BioNeutra Global BGACF Financial and Trading Overview
| BioNeutra Global stock price | 0.0056 USD |
| Previous Close | 0.0056 USD |
| Open | 0.0056 USD |
| Bid | 0.0069 USD x 11968700 |
| Ask | 10 USD x 113300 |
| Day's Range | 0.0056 - 0.0056 USD |
| 52 Week Range | 0.0056 - 0.07 USD |
| Volume | 313 USD |
| Avg. Volume | 0 USD |
| Market Cap | 260.11K USD |
| Beta (5Y Monthly) | 0.953 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
BGACF Valuation Measures
| Enterprise Value | 7.01M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.023955753 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 0.645 |
| Enterprise Value/EBITDA | -20.046 |
Trading Information
BioNeutra Global Stock Price History
| Beta (5Y Monthly) | 0.953 |
| 52-Week Change | -91.64% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 0.07 USD |
| 52 Week Low | 0.0056 USD |
| 50-Day Moving Average | 0.0056 USD |
| 200-Day Moving Average | 0.0056 USD |
BGACF Share Statistics
| Avg. Volume (3 month) | 0 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 46.45M |
| Float | 45.92M |
| Short Ratio | N/A |
| % Held by Insiders | 36.85% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2023 |
| Most Recent Quarter (mrq) | September 30, 2024 |
| Next Fiscal Year End | December 31, 2024 |
Profitability
| Profit Margin | -5.61% |
| Operating Margin (ttm) | -9.16% |
| Gross Margin | 42.84% |
| EBITDA Margin | -3.21% |
Management Effectiveness
| Return on Assets (ttm) | -3.43% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 10.86M USD |
| Revenue Per Share (ttm) | 0.23 USD |
| Quarterly Revenue Growth (yoy) | 20.30% |
| Gross Profit (ttm) | 4.65M USD |
| EBITDA | -349515 USD |
| Net Income Avi to Common (ttm) | -610205 USD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 796.54K USD |
| Total Cash Per Share (mrq) | 0.02 USD |
| Total Debt (mrq) | 7.54M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.346 |
| Book Value Per Share (mrq) | -0.12820517 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -500503 USD |
| Levered Free Cash Flow (ttm) | -1260319 USD |
Profile of BioNeutra Global
| Country | United States |
| State | BC |
| City | Vancouver |
| Address | 1030 West Georgia St. |
| ZIP | V6E 2Y3 |
| Phone | 604-210-5669 |
| Website | https://www.bioneutra.ca |
| Industry | Packaged Foods |
| Sector(s) | Consumer Defensive |
| Full Time Employees | N/A |
BioNeutra Global Corporation engages in the research and development, production, and commercialization of food for nutraceutical, functional, and mainstream food and beverage products with a focus on oligosaccharides. The company offers isomalt oligosaccharide ingredients under the VitaFiber brand for human digestive health. It operates in Canada, the United States, Australia, New Zealand, European Union, and the Asia Pacific. The company is headquartered in Vancouver, Canada.
Q&A For BioNeutra Global Stock
What is a current BGACF stock price?
BioNeutra Global BGACF stock price today per share is 0.0056 USD.
How to purchase BioNeutra Global stock?
You can buy BGACF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BioNeutra Global?
The stock symbol or ticker of BioNeutra Global is BGACF.
Which industry does the BioNeutra Global company belong to?
The BioNeutra Global industry is Packaged Foods.
How many shares does BioNeutra Global have in circulation?
The max supply of BioNeutra Global shares is 46.45M.
What is BioNeutra Global Price to Earnings Ratio (PE Ratio)?
BioNeutra Global PE Ratio is now.
What was BioNeutra Global earnings per share over the trailing 12 months (TTM)?
BioNeutra Global EPS is -0.01 USD over the trailing 12 months.
Which sector does the BioNeutra Global company belong to?
The BioNeutra Global sector is Consumer Defensive.